Financials
- Market Capitalization 225.74 M
- Employee 51
- Founded 2006
- CEO N/A
- Website www.protaratx.com
- Headquarter New York, United States
- FIGI BBG001ZLYSH5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3529 | NERV Minerva Neurosciences, Inc - Common Stock | 4.84 USD | -5.65% | +1.04% | +17.48% | +105.96% | 231.10 M USD | ||
| 3535 | GLSI Greenwich LifeSciences, Inc. - Common stock | 15.67 USD | -16.34% | -5.83% | +20.82% | +35.09% | 230.01 M USD | ||
| 3568 | KROS Keros Therapeutics, Inc. - common stock | 11.03 USD | -1.78% | -0.81% | +11.19% | -26.95% | 218.69 M USD | ||
| 3570 | VYGR Voyager Therapeutics, Inc. - Common Stock | 3.54 USD | +2.31% | +4.42% | +17.22% | -23.87% | 218.13 M USD |
Frequently asked questions about Protara Therapeutics, Inc. Common Stock
What is the Protara Therapeutics, Inc. Common Stock stock price today?
The current price of Protara Therapeutics, Inc. Common Stock (TARA) is 3.82. Over the past 24 hours, the stock has changed by -4.26%. Follow the TARA chart for real-time price dynamics.
What is the stock ticker of Protara Therapeutics, Inc. Common Stock?
Protara Therapeutics, Inc. Common Stock trades under the ticker TARA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Protara Therapeutics, Inc. Common Stock stock going up?
TARA has changed by +1.60% over the last week, +0.53% over the last month, and +22.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Protara Therapeutics, Inc. Common Stock?
Protara Therapeutics, Inc. Common Stock currently has a market capitalization of 225.74 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Protara Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Protara Therapeutics, Inc. Common Stock reported earnings of -0.36 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Protara Therapeutics, Inc. Common Stock revenue for the last quarter?
Protara Therapeutics, Inc. Common Stock reported quarterly revenue of 1.49 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Protara Therapeutics, Inc. Common Stock net income for the last quarter?
Protara Therapeutics, Inc. Common Stock reported net income of -21.67 M for the last quarter. The previous quarter showed -17.78 M, which means net income changed by -21.85%.
How many employees does Protara Therapeutics, Inc. Common Stock have?
As of the latest available data, Protara Therapeutics, Inc. Common Stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Protara Therapeutics, Inc. Common Stock stock?
You can buy Protara Therapeutics, Inc. Common Stock (TARA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Protara Therapeutics, Inc. Common Stock stock?
Investing in Protara Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TARA chart and related analysis on metatrader.com as part of your research.